Physician profile
Paul Pyo
NPI 1598919045
$1,255.38
in general payments reported to CMS, 2019-2025
18 companies · $60.93 in 2025
The $60.93 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.52 · 2020: $12.89 · 2021: $169 · 2022: $156 · 2023: $381 · 2024: $417 · 2025: $60.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781 · Education: $77.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.03 |
| Education | $77.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $412.06 | 2020-2024 | Xiaflex, Aveed, Edex |
| Astellas Pharma US INC | $128.74 | 2023-2024 | Veozah, Myrbetriq |
| Dentsply Ih Ab | $108.01 | 2023-2025 | Lofric, Lofric |
| Sumitomo Pharma America, INC. | $94.66 | 2023-2024 | Gemtesa |
| Pfizer INC. | $58.52 | 2019 | |
| Tolmar, INC. | $55.82 | 2024 | |
| Ge Healthcare | $51.15 | 2023 | |
| Axonics, INC. | $48.09 | 2023 | Axonics |
| 180 Medical, INC. | $45.98 | 2023-2024 | |
| Procept Biorobotics Corporation | $45.08 | 2024 | Aquabeam System |
| Dentsply Ih INC. | $45.04 | 2024 | Lofric |
| Teleflex LLC | $33.54 | 2022 | |
| Endo USA, INC. | $27.65 | 2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $22.85 | 2023 | |
| Myriad Genetic Laboratories, INC. | $22.09 | 2024 | Prolaris |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $20.06 | 2024 | Adstiladrin |
| Olympus America INC. | $19.35 | 2024 | Soltive |
| Boston Scientific Corporation | $16.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Pyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.